155 related articles for article (PubMed ID: 23962205)
1. High dose benzodiazepines prolong reaction times in chronic users who have major depressive and/or anxiety disorders.
Manthey L; van Loenen-Frösch F; Giltay EJ; van Veen T; Glashouwer K; Penninx BW; Zitman FG
Br J Clin Pharmacol; 2014 Mar; 77(3):571-7. PubMed ID: 23962205
[TBL] [Abstract][Full Text] [Related]
2. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety.
Manthey L; Lohbeck M; Giltay EJ; van Veena T; Zitman FG; Penninx BW
Addiction; 2012 Dec; 107(12):2173-82. PubMed ID: 22703562
[TBL] [Abstract][Full Text] [Related]
3. Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA).
Manthey L; van Veen T; Giltay EJ; Stoop JE; Neven AK; Penninx BW; Zitman FG
Br J Clin Pharmacol; 2011 Feb; 71(2):263-72. PubMed ID: 21219408
[TBL] [Abstract][Full Text] [Related]
4. [The problems with the use of benzodiazepines in elderly patients].
Bourin M
Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
[TBL] [Abstract][Full Text] [Related]
5. Perceptions, clinical characteristics, and other factors associated with prolonged and high daily dose of benzodiazepine use among patients with anxiety or depressive disorders.
Chen YT; Liu CY; Chang CM; Lai YM; Wang BH; Yang TY; Hsu SC
J Affect Disord; 2020 Jun; 271():215-223. PubMed ID: 32479319
[TBL] [Abstract][Full Text] [Related]
6. Long-term benzodiazepine use and salivary cortisol: the Netherlands Study of Depression and Anxiety (NESDA).
Manthey L; Giltay EJ; van Veen T; Neven AK; Vreeburg SA; Penninx BW; Zitman FG
J Clin Psychopharmacol; 2010 Apr; 30(2):160-8. PubMed ID: 20520289
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).
Demyttenaere K; Bonnewyn A; Bruffaerts R; De Girolamo G; Gasquet I; Kovess V; Haro JM; Alonso J
J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721
[TBL] [Abstract][Full Text] [Related]
8. [Coadministration benzodiazepine and antidepressant drugs: the state of art].
Martin P
Encephale; 2006 Oct; 32(5 Pt 1):753-66. PubMed ID: 17099600
[TBL] [Abstract][Full Text] [Related]
9. Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.
Nutt DJ
J Clin Psychiatry; 2010; 71 Suppl E1():e02. PubMed ID: 20371029
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine tapering: a prospective study.
Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
[TBL] [Abstract][Full Text] [Related]
11. Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders.
Grancini B; De Carlo V; Palazzo M; Vismara M; Arici C; Cremaschi L; Benatti B; Altamura AC; Dell'Osso B
Int Clin Psychopharmacol; 2018 May; 33(3):140-146. PubMed ID: 29461302
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption among Canadians taking benzodiazepines and related drugs.
Veldhuizen S; Wade TJ; Cairney J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):203-10. PubMed ID: 19115421
[TBL] [Abstract][Full Text] [Related]
13. The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use.
Lai IC; Wang MT; Wu BJ; Wu HH; Lian PW
J Clin Pharm Ther; 2011 Oct; 36(5):577-84. PubMed ID: 21062331
[TBL] [Abstract][Full Text] [Related]
14. Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.
Stein MD; Anderson BJ; Kenney SR; Bailey GL
J Subst Abuse Treat; 2017 Jun; 77():67-71. PubMed ID: 28476275
[TBL] [Abstract][Full Text] [Related]
15. Determinants of initiated and continued benzodiazepine use in the Netherlands study of depression and anxiety.
Manthey L; Giltay EJ; van Veen T; Neven AK; Zitman FG; Penninx BW
J Clin Psychopharmacol; 2011 Dec; 31(6):774-9. PubMed ID: 22020355
[TBL] [Abstract][Full Text] [Related]
16. Treatment inadequacy in primary and specialized care patients with depressive and/or anxiety disorders.
Bet PM; Hugtenburg JG; Penninx BW; Balkom Av; Nolen WA; Hoogendijk WJ
Psychiatry Res; 2013 Dec; 210(2):594-600. PubMed ID: 23850429
[TBL] [Abstract][Full Text] [Related]
17. The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants.
Duan Y; Wei J; Geng W; Jiang J; Zhao X; Li T; Jiang Y; Shi L; Cao J; Zhu G; Zhang K; Yu X
J Affect Disord; 2019 Sep; 256():1-7. PubMed ID: 31154087
[TBL] [Abstract][Full Text] [Related]
18. Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain.
Lopez-Peig C; Mundet X; Casabella B; del Val JL; Lacasta D; Diogene E
BMC Res Notes; 2012 Dec; 5():684. PubMed ID: 23237104
[TBL] [Abstract][Full Text] [Related]
19. One-year evolution of sleep quality in older users of benzodiazepines: a longitudinal cohort study in belgian nursing home residents.
Bourgeois J; Elseviers MM; Van Bortel L; Petrovic M; Vander Stichele RH
Drugs Aging; 2014 Sep; 31(9):677-82. PubMed ID: 25145751
[TBL] [Abstract][Full Text] [Related]
20. Socio-demographic and clinical characteristics of benzodiazepine long-term users: Results from a tertiary care center.
Cosci F; Mansueto G; Faccini M; Casari R; Lugoboni F
Compr Psychiatry; 2016 Aug; 69():211-5. PubMed ID: 27423363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
